| |
| |
|
| Insider
Information: |
Schuth Alexander O. |
| Relationship: |
COFO and Secretary |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
187,341 |
|
|
Indirect Shares
|
523,749 |
|
|
| Direct
Value |
$3,883,579 |
|
|
|
Indirect Value
|
$10,857,317 |
|
|
| Total
Shares |
711,090 |
|
|
| Total
Value |
$14,740,896 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
13
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -30.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-02-14 |
187,341 |
2024-02-14 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-09-09 |
4 |
AS |
$18.16 |
$136,200 |
I/I |
(7,500) |
610,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-10-23 |
4 |
OE |
$5.28 |
$27,081 |
D/D |
5,129 |
25,839 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-11-22 |
4 |
AS |
$18.00 |
$11,628 |
I/I |
(646) |
598,732 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-11-25 |
4 |
AS |
$18.02 |
$254,533 |
I/I |
(14,125) |
584,607 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-11-26 |
4 |
AS |
$18.02 |
$4,127 |
I/I |
(229) |
584,378 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-03 |
4 |
AS |
$18.01 |
$18,226 |
I/I |
(1,012) |
583,366 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-03 |
4 |
OE |
$5.28 |
$3,754 |
D/D |
711 |
26,550 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-03 |
4 |
AS |
$18.01 |
$12,805 |
D/D |
(711) |
25,839 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-04 |
4 |
AS |
$18.00 |
$56,178 |
D/D |
(3,121) |
25,839 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-04 |
4 |
OE |
$5.28 |
$16,479 |
D/D |
3,121 |
28,960 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-04 |
4 |
AS |
$18.00 |
$47,808 |
I/I |
(2,656) |
580,710 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2020-02-07 |
4/A |
OE |
$0.00 |
$0 |
D/D |
4,250 |
30,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2020-03-30 |
4 |
S |
$19.49 |
$27,812 |
D/D |
(1,427) |
28,662 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2020-08-20 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,643 |
616,516 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2020-08-21 |
4 |
D |
$32.88 |
$64,248 |
I/I |
(1,954) |
614,562 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-01-04 |
4 |
AS |
$65.17 |
$5,246,408 |
I/I |
(70,000) |
544,562 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-04 |
4 |
AS |
$66.65 |
$678,361 |
I/I |
(10,000) |
534,562 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-07 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,250 |
538,812 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-09 |
4 |
S |
$74.66 |
$109,809 |
I/I |
(1,468) |
537,344 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-11 |
4 |
S |
$70.17 |
$214,341 |
I/I |
(3,047) |
541,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-03-04 |
4 |
AS |
$60.89 |
$610,171 |
I/I |
(10,000) |
531,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-05-04 |
4 |
AS |
$55.09 |
$554,864 |
I/I |
(10,000) |
511,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-06-04 |
4 |
AS |
$64.35 |
$645,500 |
I/I |
(10,000) |
501,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-07-06 |
4 |
AS |
$76.20 |
$762,040 |
I/I |
(10,000) |
491,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-08-04 |
4 |
AS |
$51.52 |
$522,233 |
I/I |
(10,000) |
481,582 |
0 |
% |
|
90 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
